(1)
Response to Ustekinumab in a Patient With Severe Psoriasis When Adalimumab Dose Escalation Fails . J. Pharm. Nutr. Sci. 2014, 4 (2), 131-134. https://doi.org/10.6000/1927-5951.2014.04.02.9.